Sareum Share Discussion Threads

[z1co] 08/8/2024 12:08

wooffy , calm down

No ramp intended

[z1co] 08/8/2024 11:51

Aberystwyth

I only know just as much as you but we'll see if these rumours do materialise over the next few quarters.

[wolfofwallstreets] 08/8/2024 11:48

Thoth2 told him in a dream..

It's the licence deal that's been discussed for years..

As well as the takeover which has been expected for 20 years...

[aberystwyth] 08/8/2024 11:45

And you know this how Zico ?

[z1co] 08/8/2024 11:05

Have been BUYING the shares over the last few days ahead of further news/data and the huge licensing deal that's being formalised with GSK to be announced in Q3/Q4.

[z1co] 08/8/2024 10:58

!FOLLOWFEED
Positive Data from SDC-1801 Phase 1 Clinical Trial

Cambridge, UK, 1 July 2024 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, is pleased to announce positive topline data from its Phase 1a clinical trial of SDC-1801, a dual TYK2/JAK1 kinase inhibitor being developed as a potential new therapeutic for a range of autoimmune diseases.

Following the dosing of the final cohort in the Multiple Ascending Dose stage of the trial, and review of the initial data by the Safety Review Committee, the Company reports that:

· Blood plasma levels of SDC-1801 significantly in excess of the predicted therapeutic exposure were achieved, with a half-life of between 17 and 20 hours observed, which suggests that once-daily dosing will be possible*

· No deaths or serious adverse events due to SDC-1801 were reported

· Although data remains blinded, there appear to be no significant changes in blood cell counts or increases in serum creatinine levels, which may be dose limiting side-effects of brepocitinib, currently the most advanced TYK2/JAK1 dual inhibitor

The Company expects that further data, unblinded from drug/placebo recipients, including details of any mild or moderate adverse events and biomarkers of TYK2 and/or JAK1 inhibition, will be available in Q3 2024.

[wolfofwallstreets] 08/8/2024 09:29

Aberystwyth...

I just phoned your mummy...

But I couldn't make out what she was saying...

Her mouth sounded full...and the room.sounded busy...

[aberystwyth] 07/8/2024 22:11

Wolfie - I just phoned your mommy to let her know it's past your bedtime Nighty nighty

[wolfofwallstreets] 07/8/2024 21:03

You on your autism meds again?

Maybe ask your nurse to take your phone now and tuck you in..

[criticalthinker1] 07/8/2024 20:27

Interesting. Like all the liberals who are now aware of their misdemeanours....its happening

[wolfofwallstreets] 07/8/2024 20:24

Literally don't understand a word..
.

Sareum is going to fail...

[criticalthinker1] 07/8/2024 20:11

You know as well as anyone. appreciate the rug unique like take as im urs et al!
Any day soon...x
I'm so right about share price and ipr x

[wolfofwallstreets] 07/8/2024 19:54

Criticalstinker...

You may as well offload...

Everyone else does...

When's the takeover?

[criticalthinker1] 07/8/2024 19:45

Wolf. Would you openly pay me £200k if I was wrong about GSK. BECAUSE YOU DENOUNCE even if that I putport that Gsk would be a worthwhile affiliate?
Do you want me to offload shares tomorrow to make a market?....

[wolfofwallstreets] 07/8/2024 19:17

Critical...

Away and send an foi request to emma walmsley...

[criticalthinker1] 07/8/2024 18:43

You don't even understand what ddr or the relevance of interleukins are...jog on ...your paymasters are going to leave you high and dry you poor example of a person who wishes to see drug improvements like Sareum are undertaking denounced. Never on my watch

[criticalthinker1] 07/8/2024 18:33

So you have an open short on Sareum to support your post?

[wolfofwallstreets] 07/8/2024 18:15

Haha..
Criticalstinker got it wrong again!

Just like when you thought a FOI request applies to sareum...

Keep ramping...keep spreading nonsense..

Keep me mentioning old Thoth...

This is going to 0...

[criticalthinker1] 07/8/2024 17:56

I completely stand corrected re Stephen and GSK. I swear I saw an affiliation there albeit it may be via third parties and Barings and MGC Pharma.
The pyc rise is interesting RE AI and its previous affiliation to Sareum. If I was the CEO I would definitely be putting any data I had from trials with SDC-1801 into an AI platform to see what the machine churns out.
I think HBD on lse is quite ofay with looking at AI if memory serves me right..
The pyc rise (long overdue imo) is re prostate cancer.
Everyone on lse talking about psoriasis. Yes this is the mea culpa of certain ailments that are a prerequisite to other conditions. In my obviously and always position of talking absolute sh1te I would like to remind possible investors about lupus in which we have a robust indication re 1801 in which Thoth and I discussed..which included the USA Military. And then 1802 benefits.
All best Steadydanny
And DONT forget the patents applied for and approved and a couple still pending...
It is not by accident. And I am still awaiting the MHRA to be called out for their 'inconsistencies' in approval of some and not others.
Also note those affiliated with Riverfort via 'agreements' are removing themselves from their posts.

[wolfofwallstreets] 07/8/2024 16:06

£9 a share chat on lse!!!!

Hahahahahahagaga

Bunch of morons...

£9 is what sareum is worth for the whole "company"

[aberystwyth] 07/8/2024 16:00

Excellent easy gap up to look forward to then .. bonus - thanks peace for the info

[peaceandlove] 07/8/2024 14:38

Sareum currently down 66% year on year.

[peaceandlove] 07/8/2024 14:18

Sareum share price YTD -56%